New drug OPT101 tested for hospitalized pneumonia and sepsis patients
Disease control
Not yet recruiting
This early-stage study tests a new drug called OPT101 in 26 adults hospitalized with community-acquired pneumonia and sepsis. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either OPT101 or a placebo for up to 4 days, and re…
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC